Jilin University is a leading national research university located in Changchun, China. It is under the direct jurisdiction of China's Ministry of Education. It is a Chinese Ministry of Education Class A Double First Class University.

During the past decade, Jilin University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jilin University" are "Stroke" (3 trials), "Transient Ischemic Attack" (2 trials), "Atherosclerosis" (1 trials), "Stenosis" (1 trials) and "Stents" (1 trials). Many other conditions were trialed in "Jilin University" in a lesser frequency.

Most popular intervention types in "Jilin University" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Aspirin / Clopidogrel, Atorvastatin / Simvastatin" (1 trials), "Asprin / Clopidogrel, Atorvastatin / Simvastatin" (1 trials), "Butylphthalide Soft Capsules" (1 trials) and "Standard medical treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jilin University" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Jilin University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Jilin University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jilin University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".